University Hospital of Jaén
If you are the contact person for this centre and you wish to make any changes, please contact us.
Head of the Internal Medicine Department at the University Hospital of Jaén, Associate Professor of Medicine at the University of Jaén and member of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine
A study with Spanish participation has discovered in mice that semaglutide can improve the condition of non-alcoholic fatty liver disease not only through weight loss, but also independently, which would explain why some patients improve with minimal weight loss. “We are not saying that weight loss is unimportant, as many things improve when patients lose weight. But now we know that weight should not be the only measure of success, because GLP-1 drugs will improve liver health regardless of whether the patient loses weight or not,” the authors, who published the results in Cell Metabolism.